1887

Abstract

In Taiwan, pertussis is a notifiable disease with a low incidence in recent years, and antimicrobial susceptibility testing for the causative agent, , has not been reported to date. In May 2007, the Centers for Disease Control, Taiwan, was informed of a 1-month-old pertussis patient who did not respond to erythromycin treatment. In this study, we report the result of antimicrobial susceptibility testing performed for the suspected erythromycin-resistant isolate, as well as for an additional 27 clinical isolates that represented almost all epidemiologically unrelated isolates obtained throughout Taiwan between 2003 and 2007. All isolates were fully susceptible to azithromycin, erythromycin, clarithromycin and trimethoprim/sulfamethoxazole (MIC ≤0.047 μg ml). This result demonstrates the general susceptibility of to antimicrobial agents in Taiwan.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/002857-0
2008-12-01
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/12/1577.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/002857-0&mimeType=html&fmt=ahah

References

  1. Bartkus, J. M., Juni, B. A., Ehresmann, K., Miller, C. A., Sanden, G. N., Cassiday, P. K., Saubolle, M., Lee, B., Long, J. & other authors ( 2003; ). Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol 41, 1167–1172.[CrossRef]
    [Google Scholar]
  2. Bass, J. W. ( 1986; ). Erythromycin for treatment and prevention of pertussis. Pediatr Infect Dis 5, 154–157.[CrossRef]
    [Google Scholar]
  3. Bonacorsi, S., Farnoux, C., Bidet, P., Caro, V., Aizenfisz, S., Benhayoun, M., Aujard, Y., Guiso, N. & Bingen, E. ( 2006; ). Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate. J Clin Microbiol 44, 3830–3832.[CrossRef]
    [Google Scholar]
  4. Broder, K. R., Cortese, M. M., Iskander, J. K., Kretsinger, K., Slade, B. A., Brown, K. H., Mijalski, C. M., Tiwari, T., Weston, E. J. & other authors ( 2006; ). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55, 1–34.
    [Google Scholar]
  5. Celentano, L. P., Massari, M., Paramatti, D., Salmaso, S. & Tozzi, A. E., on behalf of the EUVAC-NET group ( 2005; ). Resurgence of pertussis in Europe. Pediatr Infect Dis J 24, 761–765.[CrossRef]
    [Google Scholar]
  6. CLSI ( 2006; ). Performance Standards for Antimicrobial Disk Susceptibility Test, 9th edn, approved standard M2–A9. Wayne, PA: Clinical and Laboratory Standards Institute.
  7. Galanakis, E., Englund, J. A., Abe, P. & Qin, X. ( 2007; ). Antimicrobial susceptibility of Bordetella pertussis isolates in the state of Washington. Int J Antimicrob Agents 29, 609–611.[CrossRef]
    [Google Scholar]
  8. Gordon, K. A., Fusco, J., Biedenbach, D. J., Pfaller, M. A. & Jones, R. N. ( 2001; ). Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 45, 3599–3600.[CrossRef]
    [Google Scholar]
  9. Hill, B. C., Baker, C. N. & Tenover, F. C. ( 2000; ). A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. J Clin Microbiol 38, 1151–1155.
    [Google Scholar]
  10. Korgenski, E. K. & Daly, J. A. ( 1997; ). Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States. J Clin Microbiol 35, 2989–2991.
    [Google Scholar]
  11. Langley, J. M., Halperin, S. A., Boucher, F. D. & Smith, B. the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) ( 2004; ). Azithryomycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 114, e96–e101.[CrossRef]
    [Google Scholar]
  12. Lewis, K., Saubolle, M. A., Tenover, F. C., Rudinsky, M. F., Barbour, S. D. & Cherry, J. D. ( 1995; ). Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 14, 388–391.[CrossRef]
    [Google Scholar]
  13. Lin, Y. C., Yao, S. M., Yan, J. J., Chen, Y. Y., Chiang, C. S., Wu, H. S. & Li, S. Y. ( 2007; ). Epidemiological shift in the prevalence of pertussis in Taiwan: implications for pertussis vaccination. J Med Microbiol 56, 533–537.[CrossRef]
    [Google Scholar]
  14. von König, C.-H. W. ( 2005; ). Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J 24, S66–S68.[CrossRef]
    [Google Scholar]
  15. Wilson, K. E., Cassiday, P. K., Popovic, T. & Sanden, G. N. ( 2002; ). Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance. J Clin Microbiol 40, 2942–2944.[CrossRef]
    [Google Scholar]
  16. Yao, S. M., Lin, Y. C., Chou, C. Y., Chen, Y. Y., Hsiao, M. J., Chen, H. Y., Yan, J. J., Su, H. P. & Li, S. Y. ( 2005; ). Antigenic divergence of Bordetella pertussis isolates in Taiwan. J Clin Microbiol 43, 5457–5461.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/002857-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/002857-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error